References
Diamond S, Dalessio DJ. Drug abuse in headache. In: Diamond S, Dalessio DJ, editors. The practising physician’s approach to headache. Baltimore: Williams & Wilkins, 1982: 114–21
Wilkinson M. Introduction. In: Diener HC, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 1–2
Mathew NT. Drug-induced headache. Neurol Clin 1990; 8: 903–12
Saper JR. Ergotamine dependency — a review. Headache 1987; 27: 435–8
Saper JR. Chronic headache syndromes. Neurol Clin 1989; 7: 387–412
Saper JR, Jones JM. Ergotamine tartrate dependency: features and possible mechanisms. Clin Neuropharmacol 1986; 9: 244–56
Andersson PG. Ergotism — the clinical picture. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 16–9
Rapoport AM, Weeks RE, Sheftell FD, et al. The ‘analgesic washout period’: a critical variable evaluation in the evaluation of headache treatment efficacy. Neurology 1986; 36 (1): 100–1
Baumgartner C, Wessely P, Bingol C, et al. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989; 29: 510–4
Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987; 27: 102–6
Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol 1982; 33: 335–41
Rapoport AM. Analgesic rebound headache. Headache 1988; 28: 662–5
Diener HC, Dichgans J, Scholz E, et al. Analgesic-induced chronic headache: longterm results of withdrawal therapy. J Neurol 1989; 236: 9–14
Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilization of medical services: a Danish population study. J Epidemiol Community Health 1992; 46: 443–6
Isler H. Headache drugs provoking chronic headache: historical aspects and common misunderstandings. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 87–94
Wolfson W, Graham J. Development of tolerance to ergot alkaloids in a patient with unusually severe migraine. N Engl J Med 1949; 241: 296–8
Peters G, Horton B. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effect. Mayo Clin Proc 1951; 26: 153–61
Ala-Hurula V, Myllyla V, Hokkanen E. Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations. Cephalalgia 1982; 2: 189–95
Tfelt-Hansen P, Krabbe A. Ergotamine abuse. Do patients benefit from withdrawal? Cephalalgia 1981; 1: 29–32
Dichgans J, Diener H-C. Clinical manifestations of excessive use of analgesic medication. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 8–15
Mathew NT, Kurman R, Perez F. Drug induced refractory headache — clinical features and management. Headache 1990; 30: 634–8
Micieli G, Manzoni GC, Granella F, et al. Clinical and epidemiological observations on drug abuse in headache patients. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 20–8
Solomon S, Lipton RB, Newman LC. Clinical features of chronic daily headache. Headache 1992; 32: 325–9
Schnider P, Aull S, Feucht M, et al. Use and abuse of analgesics in tension-type headache. Cephalalgia 1994; 14: 162–7
Silberstein SD, Saper J. Migraine: diagnosis and treatment. In: Dalessio D, Silberstein SD, editors. Wolff’s headache and other head pain. New York: Oxford University Press, 1993: 96–170
Eggen AE. The Tromsø study: frequency and predicting factors of analgesic drug use in a free-living population (12–56 years). J Clin Epidemiol 1993; 46 (11): 1297–304
Gutzwiller F, Zemp E. Der analgetikakonsum in der Bevol-kerung und socioökonomische aspekte des analgetikaabusus. In: Mihatsch MJ, editor. Das analgetikasyndrom. Stuttgart: Thieme, 1986: 197–205
Kielholz P, Ladewig D. Probleme des medikamentenmiss-brauches. Schweiz Arztezeitung 1981; 62: 2866–9
Schwarz A, Farber U, Glaeske G, et al. Daten zu analgetikakonsum and analgetikanephropathie in der bundesrepublik. Offentiches Gesundheitswesen 1985; 47: 298–300
Celentano DD, Stewart WF, Upton RB, et al. Medication use and disability among migraineurs: a national probability sample. Headache 1992; 32: 223–8
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Suppl. 7: 9–96
Robinson RG. Pain relief for headaches. Can Fam Physician 1993; 39: 867–72
Solomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache — comparison to criteria for chronic tension-type headache. Cephalalgia 1992; 12: 365–8
Messinger HB, Spierings ELH, Vincent AJP. Overlap of migraine and tension-type headache in the International Headache Society classification. Cephalalgia 1991; 11: 233–7
Silberstein SD, Lipton R, Solomon S, et al. Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 1994; 34: 1–7
Silverman K, Evans SM, Strain EC, et al. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992; 327 (16): 1109–14
Mathew NT, Stubits E, Nigam MR. Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982; 22: 66–8
Diener HC, Tfelt-Hansen P. Headache associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, editors. The headaches. New York: Raven Press, 1993: 721–7
Catarci T, Fiacco F, Argentino C, et al. Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 1994; 14: 374–5
Scholz E, Diener H-C, Geiselhart S. Drug-induced headache — does a critical dosage exist? In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 29–43
Saper JR. Headache disorders: current concepts in treatment strategies. Littleton, Massachusetts: Wright-PSG Publishers, 1983
Fisher CM. Analgesic rebound headache refuted. Headache 1988; 28: 666
Bowdler I, Killian J, Gänsslen-Blumberg S. The association between analgesic abuse and headache — coincidental or causal? Headache 1990; 30: 494
Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headache de novo? Headache 1988; 28 (1): 61–2
Dichgans J, Diener HC, Gerber WD, et al. Analgetika-induzier-ter dauerkopfschmerz. Dtsch Med Wochenschr 1984; 109: 369–73
Post RM, Silberstein SD. Shared mechanisms in affective illness, epilepsy, and migraine. Neurology 1994; 44 (7): S37–S47
Isler H. Migraine treatment as a cause of chronic migraine. In: Rose FC, editor. Advances in migraine research and therapy. New York: Raven Press, 1982: 159–64
Diamond S. Depression and headache. Headache 1983; 23: 122–6
DeBenedittis G, Lorenzetti A, Pieri A. The role of stressful life events in the onset of chronic primary headache. Pain 1990; 40: 65–75
Silberstein SD. Advances in understanding the pathophysiology of headache. Neurology 1992; 42 (2): 6–10
Saper JR. Changing perspectives of chronic headache. Clin J Pain 1986; 2: 19–28
Blumer D, Heilbronn M. Chronic pain as a variant of depressive disease: the pain-prone disorder. J Nerv Ment Dis 1982; 170: 425–31
Ward NG, Turner JA, Ready B, et al. Chronic pain, depression, and the dexamethasone suppression test. Pain 1992; 48: 331–8
Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986; 36: 995–7
Lipton RB, Tfelt-Hansen P. Neuroleptics. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press Ltd, 1993: 349–359
Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990; 30: 334–9
Diener H-C, Gerber WD, Geiselhart S, et al. Short- and long-term effects of withdrawal therapy in drug-induced headache. In: Diener H-C, Wilkinson M, editors. Drug-induced headache. Berlin: Springer-Verlag, 1988: 133–42
Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991; 337: 1442–3
Diener HC, Pfaffenrath V, Soyka D, et al. Therapie des medikamenten-induzierten dauerkopfschmerzes. Münch Med Wochenschr 1992; 134: 159–62
Lake A, Saper J, Madden S, et al. Inpatient treatment for chronic daily headache: a prospective long-term outcome [abstract]. Headache 1990; 30: 299–300
Henry P, Dartigues JF, Benetier MP, et al. Ergotamine- and analgesic-induced headaches. In: Rose C, editor. Migraine. Proceedings of the 5th International Migraine Symposium. London, 1984. London: Basel Karger, 1985: 197–205
Andersson PG. Ergotamine headache. Headache 1975; 15: 118–21
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Silberstein, S.D., Young, W.B. Analgesic Rebound Headache. Drug-Safety 13, 133–144 (1995). https://doi.org/10.2165/00002018-199513030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199513030-00001